BIOMAT Database Logo BIOMAT Database Logo

[Significance of antinuclear antibodies in the diagnosis of connective tissue diseases]. 1985

L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008947 Mixed Connective Tissue Disease A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Connective Tissue Disease, Mixed,Sharp Syndrome,MCTD,Syndrome, Sharp
D009220 Myositis Inflammation of a muscle or muscle tissue. Inflammatory Myopathy,Myositis, Focal,Myositis, Infectious,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathy,Idiopathic Inflammatory Myositis,Infectious Myositis,Inflammatory Muscle Diseases,Inflammatory Myopathies, Idiopathic,Inflammatory Myopathy, Idiopathic,Muscle Diseases, Inflammatory,Myopathies, Idiopathic Inflammatory,Myopathy, Inflammatory,Myositis, Proliferative,Focal Myositides,Focal Myositis,Infectious Myositides,Inflammatory Muscle Disease,Inflammatory Myopathies,Muscle Disease, Inflammatory,Myopathies, Inflammatory,Myopathy, Idiopathic Inflammatory,Myositides,Myositides, Focal,Myositides, Infectious,Myositides, Proliferative,Proliferative Myositides,Proliferative Myositis
D003240 Connective Tissue Diseases A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Connective Tissue Disease,Disease, Connective Tissue,Diseases, Connective Tissue
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
Significance of antinuclear factor in the connective tissue diseases.
March 1970, Annals of the rheumatic diseases,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
Antinuclear antibodies in the immunotaxonomy of connective tissue diseases.
January 1985, Scandinavian journal of rheumatology. Supplement,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
[Antinuclear antibodies in connective tissue diseases (author's transl)].
May 1978, Ryumachi. [Rheumatism],
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
[Antinuclear antibodies in children with connective tissue diseases].
January 1986, Revista do Hospital das Clinicas,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
The clinical significance of antinuclear antibodies in connective tissue disease.
May 1998, Wiener klinische Wochenschrift,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
[Connective tissue diseases and HEp-2 antinuclear antibodies].
May 1985, Minerva medica,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
The clinical relevance of antinuclear antibodies in connective tissue diseases.
January 1987, Scandinavian journal of rheumatology. Supplement,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
Antinuclear antibodies in Thai patients with connective tissue diseases.
June 1987, Asian Pacific journal of allergy and immunology,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases.
January 1984, Rheumatology international,
L M Bambara, and D Biasi, and P Caramaschi, and O Codella, and R Corrocher, and G Serpelloni, and G De Sandre
Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
January 2004, Lupus,
Copied contents to your clipboard!